In this issue
Antibodies of undetermined significance: nuisance or near miss?
Single-page reports of new alleles or antigens
The original Leukotrap
Antibody of undetermined specificity: frequency, laboratory features, and natural history
High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother–child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation
Eight-year experience of bloodless surgery at a tertiary care hospital in Korea
RHCE*cE734C allele encodes an altered c antigen and a suppressed E antigen not detected with standard reagents
A direct blood polymerase chain reaction approach for the determination of GP.Mur (Mi.III) and other Hil+ Miltenberger glycophorin variants
In vitro and in vivo quality of leukoreduced apheresis platelets stored in a new platelet additive solution
Red blood cell endothelial nitric oxide synthase does not modulate red blood cell storage hemolysis
Pathogen inactivation of platelets using ultraviolet C light: effect on in vitro function and recovery and survival of platelets
Washing of banked blood by three different blood salvage devices
Two pathogen reduction technologies—methylene blue plus light and shortwave ultraviolet light—effectively inactivate hepatitis C virus in blood products
Alloimmune platelet transfusion refractoriness circumvented by allogeneic stem cell transplantation
CD34+ cell subclasses and lymphocyte subsets in blood grafts collected after various mobilization methods in myeloma patients
The first example of a patient with etoricoxib-induced immune hemolytic anemia
SALL4 is a key transcription regulator in normal human hematopoiesis
Thrombocytopenia and platelet transfusion in UK critical care: a multicenter observational study
Patients with sickle cell anemia on simple chronic transfusion protocol show sex differences for hemodynamic and hematologic responses to transfusion
Prevalence, management, and outcomes of patients with coagulopathy after acute nonvariceal upper gastrointestinal bleeding in the United Kingdom
The role of failure modes and effects analysis in showing the benefits of automation in the blood bank
Results of lookback for Chagas disease since the inception of donor screening at New York Blood Center
Window period donations during primary cytomegalovirus infection and risk of transfusion-transmitted infections
Continuing Medical Education Program in Transfusion
Platelet recovery rate during plasma exchange predicts early and late responses in patients with thrombotic thrombocytopenic purpura (CME)
Perceived deterrents to being a plasmapheresis donor in a voluntary, nonremunerated environment
Biology of Factor XIII and clinical manifestations of Factor XIII deficiency
Contemplating the effect on blood availability if the interdonation interval of 56 days is prolonged
Therapy with fibrinogen concentrate: clinical and ethical considerations
In reply
Neonatal alloimmunization: a rare case of multiple alloantibody formation in a patient with disseminated histoplasmosis
Absence of evidence of parvovirus B19 transmission by plasma-derived clotting concentrates derived from B19V nucleic acid technology–tested plasma and including effective steps for the inactivation or removal of nonenveloped viruses
Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates
Intermittent leukocytosis in an asymptomatic platelet donor
Systemic hypersensitivity reaction mimicking anaphylaxis after first filgrastim administration in a healthy donor